HUMAN GENOME SCIENCES INC (HGSI) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 676 transactions totaling $1.1B, demonstrating a bullish sentiment with $1.0B in net insider flow. The most recent transaction on Aug 2, 2012 involved a purchase of 59,232,487 shares valued at $844.1M.
No significant insider buying has been recorded for HGSI in the recent period.
No significant insider selling has been recorded for HGSI in the recent period.
Based on recent SEC filings, insider sentiment for HGSI is bullish with an Insider Alignment Score of 96/100 and a net flow of $1.0B. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at HUMAN GENOME SCIENCES INC (HGSI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading HGSI stock, having executed 676 transactions in the past 90 days. The most active insider is Plc Glaxosmithkline (Executive), who has made 5 transactions totaling $1.1B.
Get notified when executives and directors at HGSI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 2, 2012 | Glaxosmithkline Plc | Executive | Purchase | 59,232,487 | $14.25 | $844.1M | Large |
| Aug 2, 2012 | Glaxosmithkline Plc | Executive | Purchase | 3,413,699 | $14.25 | $48.6M | Large |
| Aug 1, 2012 | Glaxosmithkline Plc | Executive | Purchase | 1,788,186 | $14.25 | $25.5M | Large |
| Aug 1, 2012 | Glaxosmithkline Plc | Executive | Purchase | 5,686,715 | $14.25 | $81.0M | Large |
| Jul 30, 2012 | C. Stump David | Executive | Tender | 19,576 | $14.25 | $279.0K | |
| Jul 30, 2012 | C. Stump David | Executive | Tender | 68,701 | $14.25 | $979.0K | Large |
| Jul 30, 2012 | Simpson Curran | Executive | Tender | 8,334 | $14.25 | $118.8K | |
| Jul 30, 2012 | Simpson Curran | Executive | Tender | 18,000 | $14.25 | $256.5K | |
| Jul 30, 2012 | Simpson Curran | Executive | Tender | 15,882 | $14.25 | $226.3K | |
| Jul 30, 2012 | D. Bateson Susan | Executive | Tender | 62,270 | $14.25 | $887.3K | Large |
| Jul 30, 2012 | H. Davis James | Executive | Tender | 165,032 | $14.25 | $2.4M | Large |
| Jul 30, 2012 | P. Southwell David | Executive | Tender | 90,835 | $14.25 | $1.3M | Large |
| Jul 30, 2012 | Labinger Barry | Executive | Tender | 49,842 | $14.25 | $710.2K | Large |
| Jul 30, 2012 | Baxter Allan | Executive | Disposition | 2,500 | $14.25 | $35.6K | |
| Jul 30, 2012 | J. Danzig Richard | Executive | Tender | 7,334 | $14.25 | $104.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 43 | $1.1B | 92.9% |
Sale(S) | 321 | $48.1M | 4.2% |
Exercise(M) | 157 | $19.3M | 1.7% |
Tender(U) | 20 | $9.7M | 0.8% |
Gift(G) | 8 | $2.4M | 0.2% |
Disposition(D) | 17 | $1.5M | 0.1% |
Award(A) | 99 | $692.8K | 0.1% |
Payment(F) | 11 | $379.2K | 0.0% |
Insiders at HUMAN GENOME SCIENCES INC are accumulating shares at an accelerated pace. With 24 insiders making 676 transactions totaling $1.1B in purchases versus $48.1M in sales, the net buying activity of $1.0B signals strong executive confidence. Plc Glaxosmithkline (Executive) leads the buying activity with $1.1B in transactions across all time.